510(k) K232084
K232084 is an FDA 510(k) premarket notification submitted by Bausch and Lomb for the device "Stellaris Elite vision enhancement system". The FDA issued a decision of Substantially Equivalent on February 26, 2024. The device falls under product code HQC (Unit, Phacofragmentation), a Class II device regulated under 21 CFR 886.4670. Bausch and Lomb has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- February 26, 2024
- Date Received
- July 13, 2023
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Unit, Phacofragmentation
- Device Class
- Class II
- Regulation Number
- 886.4670
- Review Panel
- OP
- Submission Type